| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/21/1993 | WO1993000920A1 Use of interleukine 10 to produce drugs with a tumour-inhibiting action |
| 01/21/1993 | WO1993000919A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
| 01/21/1993 | WO1993000918A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 01/21/1993 | WO1993000917A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | WO1993000910A1 Antiviral liponucleosides: treatment of hepatitis b |
| 01/21/1993 | WO1993000909A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | WO1993000893A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/21/1993 | WO1992022523A3 Peptide derivatives of collagenase inhibitor |
| 01/21/1993 | WO1992020811A3 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
| 01/21/1993 | WO1992020316A3 Targeted delivery of genes encoding immunogenic proteins |
| 01/21/1993 | DE4222647A1 Peptid-zubereitungen Peptide preparations |
| 01/21/1993 | DE4123845A1 Compsn. for treating thromboembolic disease with plasminogen activator |
| 01/21/1993 | DE4122585A1 Use of peptide fraction obtd. from organs rich in reticuloendothelial cells - for promoting weight gain in treatment of cancer and microbial infection |
| 01/21/1993 | CA2113190A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | CA2113076A1 Recombinant human interleukin 6 with homogeneous n-terminus and production thereof |
| 01/21/1993 | CA2112913A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | CA2112803A1 Antiviral liponucleosides: treatment of hepatitis b |
| 01/21/1993 | CA2112799A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | CA2112748A1 A protein kinase associated with dna repair activity |
| 01/21/1993 | CA2112580A1 2-substituted 3-(4-amidinophenyl) propionic acid derivatives, the preparation and use thereof |
| 01/21/1993 | CA2112473A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | CA2112255A1 Herpes virus proteinase and method of assaying |
| 01/21/1993 | CA2111985A1 Syringe system |
| 01/21/1993 | CA2111564A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 01/21/1993 | CA2111345A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/21/1993 | CA2110725A1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | CA2110514A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | CA2110513A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/20/1993 | EP0523948A2 Method for improving the cancer cell-killing activity of lymphocytes |
| 01/20/1993 | EP0523873A1 Non-substrate peptide inhibitors of farnesyl protein transferase |
| 01/20/1993 | EP0523776A2 Oral compositions containing a phosphopeptide |
| 01/20/1993 | EP0523675A1 Inhibitory agent against HIV superinfection |
| 01/20/1993 | EP0523449A2 Reductive amination of an aminoacid or an aminoacid derivative with an alpha-keto acid or an alpha-keto acid derivative |
| 01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
| 01/20/1993 | EP0523330A1 Implant compositions containing a biologically active protein, peptide or polypeptide |
| 01/20/1993 | EP0523140A1 Reagents and methods for modulating gene expression through rna mimicry |
| 01/20/1993 | EP0379511B1 Polypeptides with laminin activity |
| 01/20/1993 | EP0359739B1 Tranforming growth factor-beta |
| 01/20/1993 | CN1068123A Superactive grf analogs |
| 01/19/1993 | USRE34165 Pentapeptide immunoregulators |
| 01/19/1993 | US5180820 Nucleic acid sequence code |
| 01/19/1993 | US5180819 Purified myeloblastin, nucleic acid molecule encoding same, and uses thereof |
| 01/19/1993 | US5180814 Tumor specific monoclonal antibodies |
| 01/19/1993 | US5180811 Proteins having a tnf action comprising tnf-fibromectin fusion protein |
| 01/19/1993 | US5180810 Protein h capable of binding to igg |
| 01/19/1993 | US5180805 Polypeptide competitor for immunoglobulin E |
| 01/19/1993 | US5180712 Alzheimer's disease |
| 01/19/1993 | US5180711 Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 01/19/1993 | US5180678 Uses of substantially pure interleukin-9 receptor |
| 01/19/1993 | US5180668 Hirudin derivative |
| 01/19/1993 | US5180667 Genes encoding eglin C mutants |
| 01/19/1993 | US5180660 Methods and materials for HIV detection |
| 01/19/1993 | US5180583 Method for the treatment of bleeding disorders |
| 01/19/1993 | US5180582 Modified by divinyl ether-maleic anhydride copolymer, antiinflammatory agent |
| 01/19/1993 | CA1312823C Anti viral composition |
| 01/18/1993 | CA2073788A1 Oral compositions containing a phosphopeptide |
| 01/13/1993 | EP0522808A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/13/1993 | EP0522596A1 Method and means for inducing constriction of the pupil in the eye |
| 01/13/1993 | EP0522491A1 Compositions based on hyaluronic acid |
| 01/13/1993 | EP0522212A1 An agent for tyrosinase inhibition |
| 01/13/1993 | EP0522152A1 Lhrh antagonists |
| 01/13/1993 | EP0522091A1 Multiple sclerosis t-cell receptor |
| 01/13/1993 | EP0522081A1 Inhibition of disease associated with immunodeficiency virus infection |
| 01/13/1993 | EP0522080A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| 01/13/1993 | EP0522078A1 Gp75 as a tumor vaccine for melanoma |
| 01/13/1993 | EP0522073A1 Improved major histocompatibility complex (mhc) molecules |
| 01/13/1993 | EP0522070A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM) |
| 01/13/1993 | EP0522054A1 Insect retinoid receptor compositions and methods |
| 01/13/1993 | EP0522004A1 Use of copper(ii) containing compounds to accelerate wound healing |
| 01/13/1993 | EP0521963A1 Crf analogs |
| 01/13/1993 | EP0521918A1 Anti-tumour peptides |
| 01/13/1993 | EP0521873A1 Anticoagulant proteins |
| 01/13/1993 | EP0259440B1 Method of stimulating melanocytes by topical application of analogs of alpha-msh, and compositions for use in same |
| 01/13/1993 | EP0216833B1 Novel insulin derivatives and pharmaceutical preparations containing these derivatives |
| 01/12/1993 | US5179198 Glycoprotein and gene coding therefor |
| 01/12/1993 | US5179197 Removing transferrins and peroxidase from milk or whey by chromatography, desalting, absorption by ion exchange resin, elution |
| 01/12/1993 | US5179082 Method for blocking platelet adhesion to collagen |
| 01/12/1993 | US5179081 Method of treatment using an anticoagulant polypeptide |
| 01/12/1993 | US5179080 Somatomedin C hormones, carbohydrates, proteins and fats |
| 01/12/1993 | US5179078 Method of suppressing tumor formation in vivo |
| 01/12/1993 | US5179023 Genetic engineering |
| 01/12/1993 | US5179019 Therapeutic murine monoclonal antibody |
| 01/12/1993 | US5179018 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria |
| 01/12/1993 | US5179001 In cystic fibrosis patients |
| 01/12/1993 | US5178877 Cardiovascular disorders |
| 01/12/1993 | US5178864 Anticholesterol phospholipase |
| 01/12/1993 | US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes |
| 01/12/1993 | US5178858 Method for prevention of graft versus host disease |
| 01/12/1993 | US5178857 Combination of interferon-gamma and an anthelmintic |
| 01/12/1993 | US5178856 Enhancing growth of megakaryocytes in mammals using interleukin 6 |
| 01/12/1993 | US5178855 Treatment of luekocyte dysfunction with GM-CSF |
| 01/12/1993 | CA1312704C Grf analogs vii |
| 01/12/1993 | CA1312703C Derivatives of the n-arylsulphonylaminoacyl-p- amidinophenylalaninamides, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 01/12/1993 | CA1312702C Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use |
| 01/12/1993 | CA1312569C Csf and method for obtaining the same |
| 01/12/1993 | CA1312564C Monoclonal antibodies to human plasma prekallikrein and methods of preparing and using same |
| 01/12/1993 | CA1312546C Preparation of retrovirus-free immunoglobulins |
| 01/11/1993 | CA2113083A1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 01/11/1993 | CA2073499A1 Inhibitors of hiv protease useful for the treatment of aids |
| 01/11/1993 | CA2071137A1 Composition and method for revitalizing scar tissue |